Design Therapeutics
DSGN
DSGN
79 hedge funds and large institutions have $692M invested in Design Therapeutics in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 74 → 79 (+5)
4.84% more ownership
Funds ownership: 69.36% → 74.2% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
79
Holding in Top 10
3
Calls
$7.91M
Puts
$1.13M
Top Buyers
| 1 | +$32.2M | |
| 2 | +$15.1M | |
| 3 | +$9.81M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.69M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.54M |
Top Sellers
| 1 | -$8.36M | |
| 2 | -$6.67M | |
| 3 | -$5.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.94M |